Conditional gp130 deficient mouse mutants

被引:49
|
作者
Fasnacht, Nicolas [2 ]
Mueller, Werner [1 ,2 ]
机构
[1] Univ Manchester, Bill Ford Chair Cellular Immunol, Manchester M13 9PL, Lancs, England
[2] Helmholtz Ctr Infect Res, Braunschweig, Germany
关键词
gp130; Interleukin-6; Interleukin-11; Interleukin-27; Ciliary neurotropic factor; Leukemia inhibitory factor; Oncostatin M; Cardiotrophin-1; Cardiotrophin-like cytokine; Neuropoietin; Cre recombinase; Conditional mouse mutants;
D O I
10.1016/j.semcdb.2008.07.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The common cytokine receptor chain, gp130, controls the activity of a group of cytokines, namely, IL-6, IL-11, IL-27, ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), oncostatin M (OSM), cardiotrophin-1 (CT-1), cardiotrophin-like cytokine (CLC) and neuropoietin (NPN). This family of cytokines is involved in multiple different biological processes, including inflammation, acute phase response, immune responses and cell survival. To analyze the different components of the gp130 network, mouse mutants for the single cytokine were generated by conventional gene targeting. However, since the cytokines of the IL-6 family show redundancy, it does not reveal the complete picture. Therefore, the study of mice with a cell type specific inactivation of the gp130 receptor chain is an approach that will subsequently allow the dissection of the cellular cytokine network. Here, we summarize the experimental results of the conditional gp130 mutants published so far. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:379 / 384
页数:6
相关论文
共 50 条
  • [31] Requirement of gp130 signaling for the AGM hematopoiesis
    Takizawa, M
    Nobuhisa, I
    Igarashi, K
    Ueno, M
    Nakashima, K
    Kitamura, T
    Taga, T
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (04) : 283 - 289
  • [32] gp130与心肌病
    韩福生
    中国地方病学杂志, 1997, (06) : 354 - 357
  • [33] Gp130 activating mutations in inflammatory adenomas
    Zucman-Rossi, Jessica
    Amessou, Mohamed
    Bioulac-Sage, Paulette
    Rebouissou, Sandra
    M S-MEDECINE SCIENCES, 2008, 24 (12): : 1113 - 1114
  • [34] gp130 cytokine family and bone cells
    Heymann, D
    Rousselle, AV
    CYTOKINE, 2000, 12 (10) : 1455 - 1468
  • [35] SOCS3 negatively regulates gp130 cytokine signal transduction through tyrosine 759 of the gp130 receptor
    Blythe, S
    Symes, AJ
    JOURNAL OF NEUROCHEMISTRY, 2001, 78 : 151 - 151
  • [36] Defective Glycosylation Leads To Impairment of gp130 Wxpression and gp130-Dependent STAT3 Signaling in PGM3-Deficient Patients
    Barbouche, Mohamed-Ridha
    Ben-Khemis, Leila
    Mekki, Najla
    Yaakoubi, Roukaya
    Benabdessalem, Chaouki
    Ben-Mustapha, Imen
    Ben-Ali, Meriem
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (SUPPL 1) : S108 - S108
  • [37] Defective glycosylation leads to impairment of gp130 expression and gp130-dependent STAT3 signaling in PGM3-deficient patients
    Barbouche, M. R.
    Ben-Khemis, L.
    Mekki, N.
    Benabdessalem, C.
    Yaakoubi, R.
    Ben-Mustapha, I.
    Ben-Ali, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1237 - 1238
  • [38] Down-regulation of gp130 in nasopharyngeal carcinoma
    Lin, Yung-Song
    Lin, Li-Ching
    Huang, Mei-Hui
    Huang, Ai-Ju
    Huang, Yu-Tzu
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2009, 23 (01) : 28 - 32
  • [39] gp130 and the interleukin-6 family of cytokines
    Taga, T
    Kishimoto, T
    ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 797 - 819
  • [40] Association of glycoprotein gp130 with hereditary catalepsy in mice
    Kulikov, A. V.
    Sinyakova, N. A.
    Naumenko, V. S.
    Bazovkina, D. V.
    Popova, N. K.
    GENES BRAIN AND BEHAVIOR, 2010, 9 (08) : 997 - 1003